Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer

Despite recent advances in radiotherapeutic strategies, acquired resistance remains a major obstacle, leading to tumor recurrence for many patients. Once thought to be a strictly cancer cell intrinsic property, it is becoming increasingly clear that treatment-resistance is driven in part by complex...

Full description

Bibliographic Details
Main Authors: Gene Chatman Clark, James David Hampton, Jennifer E. Koblinski, Bridget Quinn, Sitara Mahmoodi, Olga Metcalf, Chunqing Guo, Erica Peterson, Paul B. Fisher, Nicholas P. Farrell, Xiang-Yang Wang, Ross B. Mikkelsen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.913656/full
_version_ 1811183067295907840
author Gene Chatman Clark
Gene Chatman Clark
James David Hampton
James David Hampton
Jennifer E. Koblinski
Jennifer E. Koblinski
Bridget Quinn
Bridget Quinn
Sitara Mahmoodi
Olga Metcalf
Chunqing Guo
Chunqing Guo
Chunqing Guo
Erica Peterson
Erica Peterson
Paul B. Fisher
Paul B. Fisher
Paul B. Fisher
Paul B. Fisher
Nicholas P. Farrell
Nicholas P. Farrell
Nicholas P. Farrell
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
Ross B. Mikkelsen
Ross B. Mikkelsen
author_facet Gene Chatman Clark
Gene Chatman Clark
James David Hampton
James David Hampton
Jennifer E. Koblinski
Jennifer E. Koblinski
Bridget Quinn
Bridget Quinn
Sitara Mahmoodi
Olga Metcalf
Chunqing Guo
Chunqing Guo
Chunqing Guo
Erica Peterson
Erica Peterson
Paul B. Fisher
Paul B. Fisher
Paul B. Fisher
Paul B. Fisher
Nicholas P. Farrell
Nicholas P. Farrell
Nicholas P. Farrell
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
Ross B. Mikkelsen
Ross B. Mikkelsen
author_sort Gene Chatman Clark
collection DOAJ
description Despite recent advances in radiotherapeutic strategies, acquired resistance remains a major obstacle, leading to tumor recurrence for many patients. Once thought to be a strictly cancer cell intrinsic property, it is becoming increasingly clear that treatment-resistance is driven in part by complex interactions between cancer cells and non-transformed cells of the tumor microenvironment. Herein, we report that radiotherapy induces the production of extracellular vesicles by breast cancer cells capable of stimulating tumor-supporting fibroblast activity, facilitating tumor survival and promoting cancer stem-like cell expansion. This pro-tumor activity was associated with fibroblast production of the paracrine signaling factor IL-6 and was dependent on the expression of the heparan sulfate proteoglycan CD44v3 on the vesicle surface. Enzymatic removal or pharmaceutical inhibition of its heparan sulfate side chains disrupted this tumor-fibroblast crosstalk. Additionally, we show that the radiation-induced production of CD44v3+ vesicles is effectively silenced by blocking the ESCRT pathway using a soluble pharmacological inhibitor of MDA-9/Syntenin/SDCBP PDZ1 domain activity, PDZ1i. This population of vesicles was also detected in the sera of human patients undergoing radiotherapy, therefore representing a potential biomarker for radiation therapy and providing an opportunity for clinical intervention to improve treatment outcomes.
first_indexed 2024-04-11T09:41:32Z
format Article
id doaj.art-f282329de9d04973b8f6e3130a15ad63
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T09:41:32Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-f282329de9d04973b8f6e3130a15ad632022-12-22T04:31:11ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.913656913656Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancerGene Chatman Clark0Gene Chatman Clark1James David Hampton2James David Hampton3Jennifer E. Koblinski4Jennifer E. Koblinski5Bridget Quinn6Bridget Quinn7Sitara Mahmoodi8Olga Metcalf9Chunqing Guo10Chunqing Guo11Chunqing Guo12Erica Peterson13Erica Peterson14Paul B. Fisher15Paul B. Fisher16Paul B. Fisher17Paul B. Fisher18Nicholas P. Farrell19Nicholas P. Farrell20Nicholas P. Farrell21Xiang-Yang Wang22Xiang-Yang Wang23Xiang-Yang Wang24Xiang-Yang Wang25Ross B. Mikkelsen26Ross B. Mikkelsen27Virginia Commonwealth University, Richmond, VA, United StatesDepartment of Biochemistry, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesDepartment of Biochemistry, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesDepartment of Pathology, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesUniversity of Virginia, Charlottesville, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesDepartment of Human Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United StatesVCU Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesVCU Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesDepartment of Human Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United StatesVCU Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University (VCU) Institute of Molecular Medicine, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesVCU Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United StatesDepartment of Chemistry, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesUniversity of Virginia, Charlottesville, VA, United StatesVCU Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University (VCU) Institute of Molecular Medicine, Virginia Commonwealth University, Richmond, VA, United StatesVirginia Commonwealth University, Richmond, VA, United StatesDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, United StatesDespite recent advances in radiotherapeutic strategies, acquired resistance remains a major obstacle, leading to tumor recurrence for many patients. Once thought to be a strictly cancer cell intrinsic property, it is becoming increasingly clear that treatment-resistance is driven in part by complex interactions between cancer cells and non-transformed cells of the tumor microenvironment. Herein, we report that radiotherapy induces the production of extracellular vesicles by breast cancer cells capable of stimulating tumor-supporting fibroblast activity, facilitating tumor survival and promoting cancer stem-like cell expansion. This pro-tumor activity was associated with fibroblast production of the paracrine signaling factor IL-6 and was dependent on the expression of the heparan sulfate proteoglycan CD44v3 on the vesicle surface. Enzymatic removal or pharmaceutical inhibition of its heparan sulfate side chains disrupted this tumor-fibroblast crosstalk. Additionally, we show that the radiation-induced production of CD44v3+ vesicles is effectively silenced by blocking the ESCRT pathway using a soluble pharmacological inhibitor of MDA-9/Syntenin/SDCBP PDZ1 domain activity, PDZ1i. This population of vesicles was also detected in the sera of human patients undergoing radiotherapy, therefore representing a potential biomarker for radiation therapy and providing an opportunity for clinical intervention to improve treatment outcomes.https://www.frontiersin.org/articles/10.3389/fonc.2022.913656/fullcancer associated fibroblasts (CAF)cancer stem cell (CSC)extracurricular vesicles (EVs)radiotherapyradioresistanceESCRT pathway
spellingShingle Gene Chatman Clark
Gene Chatman Clark
James David Hampton
James David Hampton
Jennifer E. Koblinski
Jennifer E. Koblinski
Bridget Quinn
Bridget Quinn
Sitara Mahmoodi
Olga Metcalf
Chunqing Guo
Chunqing Guo
Chunqing Guo
Erica Peterson
Erica Peterson
Paul B. Fisher
Paul B. Fisher
Paul B. Fisher
Paul B. Fisher
Nicholas P. Farrell
Nicholas P. Farrell
Nicholas P. Farrell
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
Ross B. Mikkelsen
Ross B. Mikkelsen
Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
Frontiers in Oncology
cancer associated fibroblasts (CAF)
cancer stem cell (CSC)
extracurricular vesicles (EVs)
radiotherapy
radioresistance
ESCRT pathway
title Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
title_full Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
title_fullStr Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
title_full_unstemmed Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
title_short Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
title_sort radiation induces escrt pathway dependent cd44v3 extracellular vesicle production stimulating pro tumor fibroblast activity in breast cancer
topic cancer associated fibroblasts (CAF)
cancer stem cell (CSC)
extracurricular vesicles (EVs)
radiotherapy
radioresistance
ESCRT pathway
url https://www.frontiersin.org/articles/10.3389/fonc.2022.913656/full
work_keys_str_mv AT genechatmanclark radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT genechatmanclark radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT jamesdavidhampton radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT jamesdavidhampton radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT jenniferekoblinski radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT jenniferekoblinski radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT bridgetquinn radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT bridgetquinn radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT sitaramahmoodi radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT olgametcalf radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT chunqingguo radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT chunqingguo radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT chunqingguo radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT ericapeterson radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT ericapeterson radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT paulbfisher radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT paulbfisher radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT paulbfisher radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT paulbfisher radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT nicholaspfarrell radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT nicholaspfarrell radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT nicholaspfarrell radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT xiangyangwang radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT xiangyangwang radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT xiangyangwang radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT xiangyangwang radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT rossbmikkelsen radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer
AT rossbmikkelsen radiationinducesescrtpathwaydependentcd44v3extracellularvesicleproductionstimulatingprotumorfibroblastactivityinbreastcancer